SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
408 17 0 GENT
Emcee:  rareearth42 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
208I posted a link to a medscape article on the paper and to the paper on I-Hub (Geghmm-2/27/2012
207The Lancet Publishes Results from Gentium's Phase III Defibrotide Trial for IRWIN JAMES FRANKEL-2/27/2012
206>> I was curious about some of the earlier posters when/how long they haveIRWIN JAMES FRANKEL-2/4/2012
205I didn't get what I would call a full position (maybe half) but I am not canghmm-2/3/2012
204The trade is thin. I think the selloff cleaned out those who were fearful. If IRWIN JAMES FRANKEL-2/3/2012
203Its been hard to get a lot of shares seems the stock wants to keep going up. Maghmm-2/1/2012
202Results From Gentium's Treatment IND for Defibrotide Presented at the AmericIRWIN JAMES FRANKEL-12/12/2011
201Press Release Source: Gentium S.p.A. On Tuesday October 4, 2011, 7:30 am VILLA IRWIN JAMES FRANKEL-10/4/2011
200LOL - I blew that one. :-) ijIRWIN JAMES FRANKEL-8/18/2011
199I think you may have meant to post that on the EXEL board.rkrw-8/18/2011
198Today, due to withdrawal of the NDA, the PT for GENT was reduced: - by TE from IRWIN JAMES FRANKEL-8/18/2011
197Vandetanib flanked by MTC similar to other VEGFR's losing effectiveness and IRWIN JAMES FRANKEL-7/12/2011
196Think Equity starts with buy and target of 15.IRWIN JAMES FRANKEL-7/11/2011
195Gentium Announces NDA Submission for Defibrotide Press Release Source: Gentium IRWIN JAMES FRANKEL-7/6/2011
194Gentium Signs License and Distribution Agreement for Defibrotide With Medison PhIRWIN JAMES FRANKEL-6/21/2011
193Gentium Appoints Gen Ilac as Exclusive Distributor of Defibrotide in Turkey VILIRWIN JAMES FRANKEL-6/16/2011
192Gentium Appoints Link Pharmaceuticals as Exclusive Distributor of Defibrotide inIRWIN JAMES FRANKEL-6/15/2011
191Gentium Announces MAA for Defibrotide Accepted by EMA and Will be Reviewed by CHrkrw-6/1/2011
190Unless they have lined up buyers for $30M of stock (another 3M shares) it is a lIRWIN JAMES FRANKEL-5/31/2011
189I would expect an overhang. But a lot will depend on how long it takes.rkrw-5/31/2011
188Hey Guys! What impact do you think stock offering will have? HHarold Engstrom-5/31/2011
187gentium.it Gentium Reports First Quarter Financial Results Press Release SourcIRWIN JAMES FRANKEL-5/12/2011
186Thanks Rick - I did not know that. It has been a regular hard-to-borrow stock. IRWIN JAMES FRANKEL-5/10/2011
185recently spent (at least) a few days on reg sho... don't watch the stock,scaram(o)uche-5/10/2011
184Gentium Announces Submission of a Marketing Authorization Application for DefibrIRWIN JAMES FRANKEL-5/10/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News